Display options
Share it on

Indian J Dermatol. 2016 Mar-Apr;61(2):163-8. doi: 10.4103/0019-5154.177758.

Assessment of Life Quality Index Among Patients with Acne Vulgaris in a Suburban Population.

Indian journal of dermatology

Neirita Hazarika, Radha K Rajaprabha

Affiliations

  1. Department of Dermatology, Venereology and STD, Tagore Medical College and Hospital, Chennai, Tamil Nadu, India.

PMID: 27057015 PMCID: PMC4817440 DOI: 10.4103/0019-5154.177758

Abstract

BACKGROUND AND AIMS: Acne vulgaris affects about 85% of adolescents, often extending into adulthood. Psychosocial impact of acne on health-related quality of life (QoL) has been identified, but it remains under-evaluated, especially in Indian patients. This study was aimed to assess the impact of acne and its sequelae on the QoL.

MATERIALS AND METHODS: This was a hospital-based, prospective, cross-sectional study done between June and November 2014 on 114 consenting patients above 15 years of age with acne vulgaris. Acne vulgaris and its sequelae were graded, and QoL was assessed by using Dermatology Life Quality Index (DLQI) questionnaire.

RESULTS: Most cases (64%) were between 15 and 20 years. Females (57%) outnumbered males. Facial lesions (61.4%) and grade II acne were most common. Mean DLQI score was 7.22. DLQI scores were statistically influenced by the age of the patient, duration and grade of acne, acne scar, and postacne hyperpigmentation.

CONCLUSION: This study showed significant impairment of QoL in acne patients. Assurance and counseling along with early treatment of acne vulgaris are important to reduce disease-related psychosocial sequelae and increase the efficacy of treatment.

Keywords: Acne vulgaris; Dermatology Life Quality Index; influencing factors; quality of life

References

  1. Clin Exp Dermatol. 1994 May;19(3):210-6 - PubMed
  2. Int J Dermatol. 2007 Oct;46 Suppl 1:36-8 - PubMed
  3. Health Qual Life Outcomes. 2012 Jun 06;10:60 - PubMed
  4. Am J Clin Dermatol. 2003;4(12):833-42 - PubMed
  5. Acta Derm Venereol. 2002;82(2):104-7 - PubMed
  6. Br J Dermatol. 1978 Jul;99(Suppl 16):18-9 - PubMed
  7. Clin Exp Dermatol. 2001 Jul;26(5):380-5 - PubMed
  8. J Invest Dermatol. 2011 Feb;131(2):363-70 - PubMed
  9. J Dermatol. 2015 Jul;42(7):690-6 - PubMed
  10. Br J Dermatol. 2004 Jul;151(1):183-9 - PubMed
  11. Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):454-8 - PubMed
  12. Qual Life Res. 1996 Feb;5(1):131-8 - PubMed
  13. Br J Dermatol. 1998 Nov;139(5):840-5 - PubMed
  14. An Bras Dermatol. 2011 Nov-Dec;86(6):1113-21 - PubMed
  15. Br J Dermatol. 1997 Aug;137(2):246-50 - PubMed
  16. N Z Med J. 1995 Jul 28;108(1004):287-9 - PubMed
  17. J Health Psychol. 2009 Nov;14(8):1105-18 - PubMed
  18. J Prim Health Care. 2009 Mar;1(1):20-5 - PubMed
  19. Dermatol Clin. 2012 Apr;30(2):293-300, ix - PubMed
  20. J Clin Aesthet Dermatol. 2012 Mar;5(3):51-7 - PubMed
  21. Saudi Med J. 2006 Jan;27(1):80-2 - PubMed
  22. Arch Dermatol. 1998 Apr;134(4):454-8 - PubMed
  23. J Eur Acad Dermatol Venereol. 2006 Jan;20(1):45-50 - PubMed
  24. Indian J Dermatol. 2015 Jan-Feb;60(1):33-40 - PubMed
  25. An Bras Dermatol. 2012 Nov-Dec;87(6):862-9 - PubMed
  26. Am J Clin Dermatol. 2006;7(3):185-92 - PubMed
  27. Soc Sci Med. 1995 Nov;41(10):1403-9 - PubMed
  28. Int J Dermatol. 2000 May;39(5):354-7 - PubMed
  29. Indian J Dermatol Venereol Leprol. 2009 May-Jun;75(3):323-6 - PubMed
  30. J Eur Acad Dermatol Venereol. 2007 Feb;21(2):219-26 - PubMed

Publication Types